Cargando…

Treatment of dogs with Bravecto(®) (fluralaner) reduces mosquito survival and fecundity

BACKGROUND: Mosquitoes serve as the vector of canine heartworm (Dirofilaria immitis), which represents a significant and persistent threat to canine health. A reduction in the longevity and/or reproductive success of mosquitoes that take a blood meal from fluralaner-treated dogs may consequently red...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Christopher Charles, Normile, Dorothy, Gamble, Sheryl, Guerino, Frank, Dzimianski, Michael T., Moorhead, Andrew Riddell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142166/ https://www.ncbi.nlm.nih.gov/pubmed/37106394 http://dx.doi.org/10.1186/s13071-023-05682-8

Ejemplares similares

Fluralaner (Bravecto(®)) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs
por: Duncan, Kathryn, et al.
Publicado: (2023)

Investigation of the efficacy of fluralaner spot-on (Bravecto®) against infestations of Ixodes holocyclus on cats
por: Fisara, Petr, et al.
Publicado: (2018)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto(®) Topical Solution for Cats)
por: Lavan, Robert, et al.
Publicado: (2021)

Publisher Correction: Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum(TM)) against repeated infestations with Ixodes holocyclus in dogs
por: Fisara, Petr, et al.
Publicado: (2023)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs
por: Walther, Feli M., et al.
Publicado: (2015)

Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs
por: Fisara, Petr, et al.
Publicado: (2023)

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Evaluation of oral fluralaner (Bravecto(®)) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato)
por: Allen, Kelly, et al.
Publicado: (2020)

Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog
por: Gaens, Daniela, et al.
Publicado: (2019)

Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto(®) Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis
por: Fisara, Petr, et al.
Publicado: (2019)

Comparative speed of kill of sarolaner (Simparica(™)) and fluralaner (Bravecto(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs
por: Queiroga, Tamyres Bernadete Dantas, et al.
Publicado: (2020)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Field efficacy of fluralaner (Bravecto(®) chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs
por: Chiummo, Rafael, et al.
Publicado: (2023)

Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner
por: Lavan, Robert, et al.
Publicado: (2020)

Efficacy of fluralaner flavored chews (Bravecto®) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production
por: Dryden, Michael W, et al.
Publicado: (2015)

Comparative speed of kill of oral treatments with Simparica(TM)(sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs
por: Becskei, Csilla, et al.
Publicado: (2016)

Erratum to: Efficacy of fluralaner flavored chews (Bravecto®) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production
por: Dryden, Michael W., et al.
Publicado: (2015)

Efficacy of oral fluralaner (Bravecto) against Tunga penetrans in dogs: A negative control, randomized field study in an endemic community in Brazil
por: dos Santos, Katharine Costa, et al.
Publicado: (2022)

A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index
por: Williams, Heike, et al.
Publicado: (2015)

Insecticidal efficacy of fluralaner (Bravecto(®)) against Triatoma brasiliensis, a major vector of Trypanosoma cruzi in Brazil
por: Queiroga, Tamyres Bernadete Dantas, et al.
Publicado: (2021)

A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto™) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs
por: Fisara, Petr, et al.
Publicado: (2015)

Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto(®) Chew (25 mg/kg fluralaner) or Simparica TRIO(®) (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
por: Reif, Kathryn E., et al.
Publicado: (2023)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood‐fed Phlebotomus perniciosus, a main visceral leishmaniasis vector, for at least 1 month after treatment
por: Bongiorno, G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_20bb23bd20m0mmlm24tdjhqnol